CIK 0001818382 · Non-accelerated filer<br>Smaller reporting company
Humacyte, Inc.
Sign in to watch- Ticker
- HUMA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 851763759
- Phone
- 919-313-9633
- Business address
- 2525 EAST NORTH CAROLINA HIGHWAY 54, DURHAM, NC, 27713
- Former names
- Alpha Healthcare Acquisition Corp.
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 8-K Event Executive or director change · Shareholder vote results
- 4 Open-market sale President, CEO and Director sold 630,148 shares at an average $7.17 ($4,520,024)
- 4 Open-market sale Director sold 630,148 shares at an average $7.17 ($4,520,024)
- 144 Insider Sale of Securities
- 4 Open-market buy President, CEO and Director bought 2,362 shares at $6.35 ($14,999)
- 4 Open-market buy Director bought 2,362 shares at $6.35 ($14,999)
- SC 13D/A Stake Beneficial Ownership Report
- 4 Open-market sale President, CEO and Director sold 1,001,852 shares at an average $7.82 ($7,832,200)
- 4 Open-market sale Director sold 1,001,852 shares at an average $7.82 ($7,832,200)
- 144 Insider Sale of Securities
- 4 Open-market buy President, CEO and Director bought 2,050 shares at $7.37 ($15,109)
Page 10 of 26 · 506 filings